Mitchell E Levine, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Northern Blvd, Sste 260, Great Neck, NY 11021 Phone: 516-773-7737 Fax: 516-773-7751 |
Dr. Alon Y Mogilner, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 488 Great Neck Rd, Great Neck, NY 11021 Phone: 212-263-2607 Fax: 212-263-4061 |
Dr. Sheng-fu Larry Lo, MD, MHS, FAANS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 805 Northern Blvd Ste 100, Great Neck, NY 11021 Phone: 516-562-4256 Fax: 516-562-2635 |
David Weintraub, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 611 Northern Blvd Ste 150, Great Neck, NY 11021 Phone: 516-325-7000 |
Daniel Green Eichberg, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 805 Northern Blvd Ste 100, Great Neck, NY 11021 Phone: 516-550-2100 |
Syed Hasan Naqvi, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 560 Northern Blvd, Ste 206, Great Neck, NY 11021 Phone: 516-466-5166 Fax: 516-466-7828 |
Mark Eisenberg, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Nslij -department Of Neurosurgery, 900 Northern Boulevard, Great Neck, NY 11021 Phone: 516-773-7737 |
Dr. Ashesh Dinesh Mehta, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 611 Northern Blvd, Great Neck, NY 11021 Phone: 516-325-7061 Fax: 516-325-7001 |
News Archive
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
Overall though, people are not as concerned as they were in the last survey in summer 2018.
New technology by Neurodata Lab is capable to acquire physiological data by simply pointing a webcam at one's face, with accuracy comparable to special wearable equipment.
A U.S. health task force stunned much of the medical world and many women in November 2009 by recommending that most women didn't need to get their first mammogram until age 50.
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
› Verified 7 days ago